Michael Kirstgen

Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids

Michael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Müller et al. · Scientific Reports · 2020 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Substrate Specificities and Inhibition Pattern of the Solute Carrier Family 10 Members NTCP, ASBT and SOAT

Gary Grosser, Simon Müller, Michael Kirstgen et al. · Frontiers in Molecular Biosciences · 2021 · 32 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

Massimo Palatini, Simon Müller, Michael Kirstgen et al. · Viruses · 2022 · 29 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Long-term <i>trans</i>-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid

Kira A. A. T. Lowjaga, Michael Kirstgen, Simon Müller et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2020 · 17 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening

Michael Kirstgen, Simon Müller, Kira Alessandra Alicia Theresa Lowjaga et al. · Viruses · 2021 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16